Number of COVID-19 infections missed by lateral flow tests ‘substantial enough to be of clinical importance’
The proportion of people with current COVID-19 infection missed by the Innova lateral flow test (LFT) is substantial enough to be of clinical importance, particularly when testing people without symptoms, warn experts in The BMJ today.